Mayne Pharma to present at Jeffries Healthcare Conference
Released
Released
Announcement PDF
ASX Announcement
MAYNE PHARMA TO PRESENT AT THE JEFFERIES
HEALTHCARE CONFERENCE IN NEW YORK CITY
23 May 2023, Adelaide, Australia: Mayne Pharma Group Limited (ASX: MYX) today announced that
Shawn Patrick O’Brien, Chief Executive Officer, and Aaron Gray, Chief Financial Officer of Mayne
Pharma, will present at the Jefferies Healthcare Conference in New York City as follows:
Date:
Time:
Webcast:
Friday, June 9, 2023
11:00am US Eastern Time
Click here
A copy of the presentation slides will be provided to ASX prior to the presentation. The live and
archived webcast of the presentation will be accessible from the Company’s website
www.maynepharma.com under Investor Relations. The replay of the webcast will be accessible for
90 days.
To schedule a 1-on-1 meeting with the Company, please contact Corporate Access at Jefferies.
For further information contact:
Australia:
Craig Haskins
+61 421 029 843
ir@maynepharma.com
US:
Lisa M. Wilson
+917 543 9932
ir@maynepharma.com
Authorised for release to the ASX by the Chair
About Mayne Pharma
Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercialising
novel pharmaceuticals, offering patients better, safe and more accessible medicines. Mayne
Pharma also provides contract development and manufacturing services to clients worldwide.
Mayne Pharma has a 40- year track record of innovation and success in developing new oral drug
delivery systems. These technologies have been successfully commercialised in numerous products
that continue to be marketed around the world. To learn more about Mayne Pharma, please visit
maynepharma.com.
Share your feedback
Discover